Investor Summary

RxCritical is seeking sophisticated investors interested in this ground-breaking opportunity with a low entry point and maximum return on investment!

Demand is on the rise due to an impending regulatory storm, and RxCritical is well positioned to offer the ideal solution and capture a significant portion of the market.

To obtain a copy of the investor summary please contact Vish Joshi, President & CEO by e-mail vjoshi@rxcritical.ca or by phone 1.800.905.1020 Ext. 201.

To discuss the investor summary please contact Vish Joshi, President & CEO by e-mail vjoshi@rxcritical.ca or by phone 1.800.905.1020 Ext. 201.